|
AMRN | Amarin Corp Plcuk |
|
|
AMRN | Amarin Corp Plcuk |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.08 |
| Leverage | 30.45% |
| Market Cap | $ 5.9B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -85.9m |
| Margin | -38.06% |
Amarin Corporation plc, a pharmaceutical company, is engaged in the development and commercialization of therapies for the treatment of cardiovascular disease in the United States. The company is headquartered in Dublin, Ireland.